You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer

Alerts

Article menu
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0185: Biweekly Paclitaxel/Carboplatin (Tc) Combination Chemotherapy is Highly Active and Well-Tolerated Treatment in First Line Chemotherapy for Ovarian Cancer
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address